Douglas Kerr reports a stock award at Dyne Therapeutics
By AlphaYouPublished Form 4
Kerr Douglas
Reporting filer
Douglas Kerr reports a stock award, not an open-market purchase or sale, in Dyne Therapeutics, Inc.. Form 4 filed Oct 22, 2026 lists 2 entries.
- Disclosed
- Oct 22, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Kerr Douglas | 2026-10-20 | A | Grant or award | 8000 | 0 | 170,564 | 2 days | Filed terms
|
| Stock option (right to buy) (derivative) | Kerr Douglas | 2026-10-20 | A | Grant or award | 12000 | 0 | 12,000 | 2 days | Filed terms
|
Common Stock
- Owner
- Kerr Douglas
- Date
- 2026-10-20
- Code
- A
- Action
- Grant or award
- Quantity
- 8000
- Price
- 0
- Following holdings
- 170,564
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-20
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 8000
- id: F1
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 170564
- id: F2
- direct Or Indirect Ownership: D
Stock option (right to buy) (derivative)
- Owner
- Kerr Douglas
- Date
- 2026-10-20
- Code
- A
- Action
- Grant or award
- Quantity
- 12000
- Price
- 0
- Following holdings
- 12,000
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Stock option (right to buy)
- conversion Or Exercise Price: 16.27
- transaction Date: 2026-10-20
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 12000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F3
- expiration Date: 2036-10-19
- underlying Security Title: Common Stock
- underlying Security Shares: 12000
- shares Owned Following Transaction: 12000
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Kerr Douglas: Head of R&D and CMO.
- F1: Consists of shares of Common Stock issuable under 8,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal quarterly installments over four years with the first installment vesting on January 20, 2027.
- F2: Includes 133,126 unvested RSUs.
- F3: This option was granted on October 20, 2026. The shares underlying the option are scheduled to vest over four years in equal monthly installments through October 20, 2030.
Original sources
Prepared automatically from public filing data. Report a correction.